The goal of this study is to validate the effectiveness of a new diagnostic tool. With your help, we will be able to begin to prove this test works in the way we expect, and the new diagnostic test will be used to improve cancer care for patients worldwide.
If you decide to join this study, you may be asked to complete a few survey questions. There are no procedures required for your participation in this study. Instead, the study team will use a portion of your existing tumor biopsy or one that your doctor will collect as part of the treatment plan for your condition. Your involvement will be minimal and we estimate your participation will be a day or less.
Your personal information will be kept secure and private. Only a “participant study number” will be used when presenting your data to anyone outside of the study team.
There are no direct benefits to participating in this study. By participating, you will help advance medical care and improve outcomes for future cancer patients.
Data will be anonymized and shared with the research sponsor. If the sponsor discovers significant results from their data analysis, they may decide to run another study in the future.
, the study sponsor, is a United States-based company with the goal of leveraging their unique platform to enable medical research and personalized medicine.